CRV 431

Drug Profile

CRV 431

Alternative Names: CRV431

Latest Information Update: 15 Sep 2016

Price : $50

At a glance

  • Originator ContraVir Pharmaceuticals
  • Class Antivirals; Ciclosporins
  • Mechanism of Action Cyclophilin inhibitors; Sodium-bile acid cotransporter modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Hepatitis B

Most Recent Events

  • 12 Sep 2016 New pharmacodynamics data from preclinical study presented at The Liver Meeting® 2016: 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2016) and The International Liver Congress™ 2016 (ILC-2016)
  • 20 Jul 2016 Preclinical trials in Hepatitis B treatment in USA (PO) before July 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top